Skip to content
★ Sign in to follow
ML

Mark Landy

Mimedx Group, Inc.MIV Therapeutics Inc
Total declarations
19
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 29 Jul 2019 for Mimedx Group, INC., €13k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Mark Landy: trading record in brief

This profile gathers the share dealings of Mark Landy across 2 companies, led by MIV Therapeutics Inc and Mimedx Group, Inc. In total, 19 filings cover trades dated from 16 November 2006 to 26 July 2019.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 29 July 2019: a share grant of €2,890, in Mimedx Group, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Mark Landy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    14,466 USD11SEC
    2,809 shares@ US$5.151.9% of flowCommon StockSEC:0001376339-19-000032:0
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    3,221 USD11SEC
    602 shares@ US$5.350.4% of flowCommon StockSEC:0001376339-19-000032:1
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    251,293 USD14SEC
    104,271 shares@ US$2.4133.4% of flowCommon StockSEC:0001376339-19-000016:0
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    421,750 USD17SEC
    175,000 shares@ US$2.4156.0% of flowCommon StockSEC:0001376339-19-000016:1
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    9,289 USD11SEC
    2,949 shares@ US$3.151.2% of flowCommon StockSEC:0001376339-19-000011:0
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    6,429 USD11SEC
    2,041 shares@ US$3.150.8% of flowCommon StockSEC:0001376339-19-000011:1
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    1,097 USD11SEC
    708 shares@ US$1.550.1% of flowCommon StockSEC:0001376339-18-000050:0
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    46,200 USD12SEC
    30,000 shares@ US$1.546.0% of flowCommon StockSEC:0001364726-18-000007:0
  • ◆
    EVP & Chief Strategy OfficerExecutivesMimedx Group, Inc.
    0SEC
    0@ €1.356Common StockSEC:0001364726-18-000005:0
  • ◆
    President & CEOExecutivesMIV Therapeutics Inc
    0SEC
    367,139 shares0Common StockSEC:0001001277-08-000154:0
  • ◆
    President & CEOExecutivesMIV Therapeutics Inc
    167,493 USD0SEC
    837,464 shares@ US$0.20Common StockSEC:0001001277-08-000143:0
  • ◆
    President & CEOExecutivesMIV Therapeutics Inc
    0SEC
    45,634 shares0Common StockSEC:0001001277-08-000141:0
  • ◆
    President & CEOExecutivesMIV Therapeutics Inc
    0SEC
    64,954 shares0Common StockSEC:0001001277-08-000108:0
  • ◆
    PresidentExecutivesMIV Therapeutics Inc
    34,199 USD0SEC
    62,180 shares@ US$0.55commonSEC:0001303600-08-000004:0
  • ◆
    PresidentExecutivesMIV Therapeutics Inc
    50,000 USD0SEC
    83,333 shares@ US$0.60optionsSEC:0001303600-07-000042:0
  • ◆
    PresidentExecutivesMIV Therapeutics Inc
    25,673 USD0SEC
    64,183 shares@ US$0.40commonSEC:0001303600-07-000004:0
  • ◆
    PresidentExecutivesMIV Therapeutics Inc
    19,927 USD0SEC
    49,817 shares@ US$0.40commonSEC:0001303600-07-000004:1

17 of 17 declarations